Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years [Yahoo! Finance]
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Yahoo! Finance
But that scarcely detracts from the really solid long term returns generated by the company over five years. Indeed, the share price is up an impressive 134% in that time. To some, the recent pullback wouldn't be surprising after such a fast rise. The more important question is whether the stock is too cheap or too expensive today. Since the long term performance has been good but there's been a recent pullback of 7.4%, let's check if the fundamentals match the share price. See our latest analysis for Evolent Health Evolent Health wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit. In the last 5 years Evo
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
- Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024PR Newswire
- Exclusive: Inside Wiz's acquisition of Gem Security [Fortune]Fortune
- Define Ventures Welcomes Frank Williams as Venture Partner [Yahoo! Finance]Yahoo! Finance
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $45.00 to $44.00. They now have a "buy" rating on the stock.MarketBeat
EVH
Earnings
- 2/22/24 - Beat
EVH
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- EVH's page on the SEC website